(Q33414825)

26 July 2017

title

A review of the management of childhood immune thrombocytopenia: how can we provide an evidence-based approach? (English)

1 reference

26 July 2017

1 reference

Nichola Cooper

1

1 reference

26 July 2017

language of work or name

English

0 references

publication date

25 April 2014

1 reference

British Journal of Haematology

26 July 2017

published in

1 reference

26 July 2017

volume

165

1 reference

26 July 2017

issue

6

1 reference

26 July 2017

page(s)

756-767

1 reference

Chronic immune thrombocytopenic purpura in children: a survey of the canadian experience

26 July 2017

cites work

1 reference

Clinical and therapeutic experience in 712 Israeli patients with idiopathic thrombocytopenic purpura. Israeli ITP Study Group

21 January 2018

1 reference

Fatigue as marker of thrombocytopenia in childhood idiopathic thrombocytopenic purpura.

21 January 2018

1 reference

Thrombopoietin receptor agonist therapy in primary immune thrombocytopenia is associated with bone marrow hypercellularity and mild reticulin fibrosis but not other stromal abnormalities

21 January 2018

1 reference

Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia

21 January 2018

1 reference

Childhood immune thrombocytopenia: a changing therapeutic landscape

21 January 2018

1 reference

Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy

21 January 2018

1 reference

Thrombocytopenic syndromes masquerading as childhood immune thrombocytopenic purpura

21 January 2018

1 reference

AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP.

21 January 2018

1 reference

Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP.

21 January 2018

1 reference

A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia

21 January 2018

1 reference

Is bone marrow aspiration needed in acute childhood idiopathic thrombocytopenic purpura to rule out leukemia?

21 January 2018

1 reference

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

21 January 2018

1 reference

Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study

21 January 2018

1 reference

Intracranial hemorrhage in childhood immune thrombocytopenic purpura

21 January 2018

1 reference

Platelets can enhance vascular permeability

21 January 2018

1 reference

The long-term impact of rituximab for childhood immune thrombocytopenia

21 January 2018

1 reference

Repeated courses of rituximab for autoimmune cytopenias may precipitate profound hypogammaglobulinaemia requiring replacement intravenous immunoglobulin

21 January 2018

1 reference

Toxicities of the thrombopoietic growth factors

21 January 2018

1 reference

Evidence-based mini-review: Is indium-labeled autologous platelet scanning predictive of response to splenectomy in patients with chronic immune thrombocytopenia?

21 January 2018

1 reference

Management of acute childhood idiopathic thrombocytopenic purpura according to AIEOP consensus guidelines: assessment of Italian experience

21 January 2018

1 reference

RhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME)

21 January 2018

1 reference

Cytomegalovirus can make immune thrombocytopenic purpura refractory

21 January 2018

1 reference

Intracranial hemorrhage in acute and chronic childhood immune thrombocytopenic purpura over a ten-year period: an Egyptian multicenter study

21 January 2018

1 reference

Romiplostim in children with chronic refractory ITP: randomized placebo controlled study

21 January 2018

1 reference

Cognitive symptoms are common in immune thrombocytopenia and associate with autonomic symptom burden

21 January 2018

1 reference

Diagnosis of immune thrombocytopenic purpura in children

21 January 2018

1 reference

Bone marrow fibrosis in 66 patients with immune thrombocytopenia treated with thrombopoietin-receptor agonists: a single-center, long-term follow-up

21 January 2018

1 reference

Changing trends in the UK management of childhood ITP.

21 January 2018

1 reference

Intracranial hemorrhage in children with immune thrombocytopenic purpura. Japanese Study Group on childhood ITP.

21 January 2018

1 reference

Diagnostic value of bone marrow examination in isolated thrombocytopenia

21 January 2018

1 reference

The role of the bone marrow examination in the diagnosis of immune thrombocytopenic purpura: case series and literature review

21 January 2018

1 reference

Patterns of inpatient care for newly diagnosed immune thrombocytopenia in US children's hospitals

21 January 2018

1 reference

Validity, reliability, and responsiveness of a new measure of health-related quality of life in children with immune thrombocytopenic purpura: the Kids' ITP Tools.

21 January 2018

1 reference

Pilot study of the effect of romiplostim on child health-related quality of life (HRQoL) and parental burden in immune thrombocytopenia (ITP).

21 January 2018

1 reference

Quality of life in childhood immune thrombocytopenia: international validation of the kids' ITP tools

21 January 2018

1 reference

Splenectomy in children with idiopathic thrombocytopenic purpura: A prospective study of 134 children from the Intercontinental Childhood ITP Study Group

21 January 2018

1 reference

Romiplostim or standard of care in patients with immune thrombocytopenia

21 January 2018

1 reference

Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy

21 January 2018

1 reference

Combination of recombinant factor VIIa and fibrinogen corrects clot formation in primary immune thrombocytopenia at very low platelet counts

21 January 2018

1 reference

Rituximab for children with immune thrombocytopenia: a systematic review

21 January 2018

1 reference

Intracranial haemorrhage in idiopathic thrombocytopenic purpura. Paediatric Haematology Forum of the British Society for Haematology

21 January 2018

1 reference

Elective splenectomy in children with idiopathic thrombocytopenic purpura

21 January 2018

1 reference

Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura

21 January 2018

1 reference

Relationships among bleeding severity, health-related quality of life, and platelet count in children with immune thrombocytopenic purpura

21 January 2018

1 reference

The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia

21 January 2018

1 reference

Bleeding manifestations and management of children with persistent and chronic immune thrombocytopenia: data from the Intercontinental Cooperative ITP Study Group (ICIS).

21 January 2018

1 reference

Idiopathic thrombocytopenic purpura in childhood: a 10-year audit

21 January 2018

1 reference

Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia

21 January 2018

1 reference

International consensus report on the investigation and management of primary immune thrombocytopenia

21 January 2018

1 reference

Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases

21 January 2018

1 reference

Short- and long-term risks of splenectomy for benign haematological disorders: should we revisit the indications?

21 January 2018

1 reference

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

21 January 2018

1 reference

Duration and morbidity of chronic immune thrombocytopenic purpura in children: five-year follow-up of a Nordic cohort

21 January 2018

1 reference

Effect of eradication of Helicobacter pylori in children with chronic immune thrombocytopenia: a prospective, controlled, multicenter study.

21 January 2018

1 reference

Experiences with recombinant FVIIa in the emergency treatment of patients with autoimmune thrombocytopenia: a review of the literature

21 January 2018

1 reference

Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study

21 January 2018

1 reference

21 January 2018

1 reference

Autologous 111 In-labelled platelet sequestration studies in patients with primary immune thrombocytopenia (ITP) prior to splenectomy: a report from the United Kingdom ITP Registry

21 January 2018

1 reference

Platelets and the immune continuum

21 January 2018

1 reference

A nationwide survey of newly diagnosed childhood idiopathic thrombocytopenic purpura in Japan

21 January 2018

1 reference

Possible lower rate of chronic ITP after IVIG for acute childhood ITP an analysis from registry I of the Intercontinental Cooperative ITP Study Group (ICIS).

21 January 2018

1 reference

Risk for hospital contact with infection in patients with splenectomy: a population-based cohort study

21 January 2018

1 reference

Risk of venous thromboembolism in splenectomized patients compared with the general population and appendectomized patients: a 10-year nationwide cohort study

21 January 2018

1 reference

Does treatment of newly diagnosed idiopathic thrombocytopenic purpura reduce morbidity?

21 January 2018

1 reference

Mortality risk in splenectomised patients: a Danish population-based cohort study

21 January 2018

1 reference

Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment

21 January 2018

1 reference

Analysis of health-related quality of life in children with immune thrombocytopenia and their parents using the kids' ITP tools

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJH.12889

1 reference

26 July 2017

1 reference